Skip to main content
2024 Guide to Patient Support Services

AVEO Pharmaceuticals

2024 PSS Guide

AVEO ACE

AVEO Pharmaceuticals offers AVEO ACE, a comprehensive program dedicated to providing personalized support to patients and their caregivers while taking Fotivda treatment (Table).

AVEO ACE

AVEO ACE Program Specialists are committed to helping patients access Fotivda, regardless of insurance circumstance. They can provide support, including insurance coverage support and financial assistance, as well as ongoing education.

Insurance Coverage Support

Insurance coverage support through AVEO ACE includes benefit investigation, prior authorization navigation, appeals information, the Quick Start Program, and the Bridge Program. The Quick Start Program provides free Fotivda to eligible patients who experience a payer decision delay of 5 business days or more. The Bridge Program provides free Fotivda to eligible patients who experience coverage interruptions while already on treatment.

To learn more or to enroll your patient, call 833-368-4832, or visit Insurance Coverage Support.

AVEO ACE Co-pay Assistance Program

Patients who have commercial or private insurance may be eligible to enroll in the AVEO ACE Co-pay Assistance Program.

To enroll your patient, please visit AVEO ACE Co-pay Assistance Program.

AVEO ACE Patient Assistance Program

Patients who are uninsured or underinsured may access Fotivda through the AVEO ACE Patient Assistance Program.

To enroll your patient, please visit AVEO ACE Patient Assistance Program.

TABLE AVEO Pharmaceuticals Oncology Drug

Drug
Indications
Patient support programs

Drug
Fotivda (tivozanib) capsules, for oral use
Indications
Treatment of adult patients with relapsed or refractory advanced renal-cell carcinoma following 2 or more prior systemic therapies
Patient support programs